Effects of Helicobacter pylori infection in gastrointestinal tract malignant diseases: From the oral cavity to rectum

doi:10.4251/wjgo.v14.i1.55

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 1

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6182)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-7) series.

Item

Count

PDF

286

WORD

198

HTML

3234

Figures (1-1)

371

Tables (1-7)

425

Sum=4514

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

468

Download

1200

Sum=1668

Jan 15, 2022 (publication date) through Mar 7, 2025

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Oncol. Jan 15, 2022; 14(1): 55-74
Published online Jan 15, 2022. doi: 10.4251/wjgo.v14.i1.55

Table 4 Association with Helicobacter pylori infection and Esophageal cancer

	Prevalence of H. pylori	Diagnostic tool of H. pylori	Study design	P value
Rokkas et al[44]	EAC: 0.52 (95%CI: 0.37-0.73)	Serology and/or histology	Meta-analysis	EAC: P < 0.001
Rokkas et al[44]	ESCC: 0.85 (95%CI: 0.55-1.33)	Serology and/or histology	Meta-analysis	ESCC: P = 0.48
Islami et al[45]	EAC: 0.56 (95%CI: 0.46-0.68)	Serology and/or histology	Meta-analysis	NA
Islami et al[45]	ESCC: 1.10 (95%CI: 0.78-1.55)	Serology and/or histology	Meta-analysis	NA
Nie et al[46]	EAC: 0.57 (95%CI: 0.44-0.73)	Serology and/or histology; rapid urease test	Meta-analysis	NA
Nie et al[46]	ESCC:1.16 (95%CI: 0.8.-1.60)	Serology and/or histology; rapid urease test	Meta-analysis	NA
Xie et al[47]	EAC: 0.59 (95%CI: 0.51-0.68)	Serology and/or histology; rapid urease test	Meta-analysis	NA
	ESCC: 0.97 (95%CI: 0.76-1.24)
	ESCC in Eastern: 0.66 (95%CI: 0.43-0.89)

CI: Confidence interval; H. pylori: Helicobacter pylori; EAC: Esophageal adenocarcinoma; ESCC: Esophageal squamous-cell carcinoma; NA: Not available.

Citation: Kuo YC, Yu LY, Wang HY, Chen MJ, Wu MS, Liu CJ, Lin YC, Shih SC, Hu KC. Effects of Helicobacter pylori infection in gastrointestinal tract malignant diseases: From the oral cavity to rectum. World J Gastrointest Oncol 2022; 14(1): 55-74
URL: https://www.wjgnet.com/1948-5204/full/v14/i1/55.htm
DOI: https://dx.doi.org/10.4251/wjgo.v14.i1.55